{ "version": "1.0.0", "title": "Life Sciences IPO Evidence History source ledger", "dataCollected": "2026-09", "firstPublished": "2026-09", "eventWindow": { "from": "2025-07-01", "to": "latest EDGAR index available when collected, September 2026" }, "quarters": [ { "id": "2025-Q3", "complete": true }, { "id": "2025-Q4", "complete": true }, { "id": "2026-Q1", "complete": true }, { "id": "2026-Q2", "complete": true }, { "id": "2026-Q3", "complete": false } ], "screening": { "prospectusesScreened": 730, "issuersScreened": 624, "exclusions": { "notLifeSciences": 519, "priorReporter": 58, "noS1": 3, "formF1": 4 }, "excludedAfterReview": [ "Functional Brands Inc.: dietary supplement manufacturer and distributor, not a drug, device or care-delivery business", "Research Alliance Corp III: blank check company (SPAC) despite a pharmaceutical SIC code" ] }, "issuers": [ { "id": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3845, "sicDescription": "Electromedical & Electrotherapeutic Apparatus", "sectorBasis": "SEC SIC 3845 (Electromedical & Electrotherapeutic Apparatus); prospectus business description read and consistent", "profile": "Commercial-stage capsule endoscopy imaging with AI-assisted reading", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "CV" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-07-03", "pricingAccession": "0001193125-25-155088", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525155088/d916440d424b4.htm", "firstPublicFilingDate": "2025-02-07", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-05-09", "daysFirstPublicToPricing": 146, "s1Amendments": 3, "staffCommentLetters": 3, "issuerResponses": 4, "themes": { "clinical": { "pivotal": 44 }, "regulatory": { "510k": 145, "pma-denovo": 38, "breakthrough-device": 7, "eu-mdr": 11 }, "quality": { "cgmp": 2, "cdmo": 16, "qsr": 2, "inspection": 2, "recall": 13 }, "commercial": { "reimbursement": 55, "coding": 2, "medicare": 24, "payer": 37, "sales-force": 15 }, "compliance": { "hipaa": 6, "anti-kickback": 7 }, "financial": { "going-concern": 1, "material-weakness": 4, "egc": 21, "runway": 4 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Commercial-stage personalized spine surgery implants and planning software", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "CARL" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-07-24", "pricingAccession": "0000950170-25-098125", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025098125/carl_-_424b4_-_july_2025.htm", "firstPublicFilingDate": "2025-04-24", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-06-26", "daysFirstPublicToPricing": 91, "s1Amendments": 1, "staffCommentLetters": 2, "issuerResponses": 5, "themes": { "clinical": { "clinical-hold": 1 }, "regulatory": { "510k": 66, "pma-denovo": 46, "breakthrough-device": 15, "eu-mdr": 1 }, "quality": { "cgmp": 6, "cdmo": 62, "qsr": 7, "inspection": 6, "recall": 34 }, "commercial": { "reimbursement": 91, "medicare": 66, "payer": 77, "sales-force": 4 }, "compliance": { "hipaa": 6, "anti-kickback": 10, "cpom": 2 }, "financial": { "egc": 23 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Commercial-stage shoulder replacement systems", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "NYSE" ], "tickers": [ "SI" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-08-01", "pricingAccession": "0001628280-25-037109", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025037109/shoulderinnovation-final42.htm", "firstPublicFilingDate": "2025-04-17", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-07-07", "daysFirstPublicToPricing": 106, "s1Amendments": 3, "staffCommentLetters": 4, "issuerResponses": 5, "themes": { "clinical": { "clinical-hold": 1, "clinical-validation": 1 }, "regulatory": { "510k": 57, "pma-denovo": 65, "eu-mdr": 2 }, "quality": { "cgmp": 6, "cdmo": 9, "qsr": 14, "inspection": 7, "recall": 36 }, "commercial": { "reimbursement": 41, "coding": 5, "medicare": 39, "payer": 58, "value-based": 1, "sales-force": 6 }, "compliance": { "hipaa": 5, "anti-kickback": 11 }, "financial": { "egc": 30 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Commercial-stage AI software for non-invasive coronary artery disease diagnosis from CT scans", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "HTFL" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-08-08", "pricingAccession": "0001628280-25-039265", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025039265/heartflowinc-424b4.htm", "firstPublicFilingDate": "2025-02-06", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-07-17", "daysFirstPublicToPricing": 183, "s1Amendments": 2, "staffCommentLetters": 4, "issuerResponses": 3, "themes": { "clinical": { "clinical-hold": 1, "clinical-validation": 27 }, "regulatory": { "510k": 30, "pma-denovo": 48, "breakthrough-device": 4, "eu-mdr": 16 }, "quality": { "cgmp": 2, "qsr": 10, "inspection": 4, "recall": 17 }, "commercial": { "reimbursement": 78, "coding": 22, "medicare": 60, "payer": 67, "sales-force": 4 }, "compliance": { "hipaa": 28, "anti-kickback": 18, "stark": 2, "cpom": 1 }, "financial": { "egc": 21 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Development-stage botanical drugs for inflammatory diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "NV", "exchanges": [ "Nasdaq" ], "tickers": [ "CURX" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-08-26", "pricingAccession": "0001493152-25-012350", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225012350/form424b4.htm", "firstPublicFilingDate": "2024-06-20", "firstPublicFilingForm": "DRS", "firstS1Date": "2024-10-16", "daysFirstPublicToPricing": 432, "s1Amendments": 6, "staffCommentLetters": 5, "issuerResponses": 8, "themes": { "clinical": { "phase-1": 11, "phase-2": 15, "phase-3": 5, "clinical-hold": 3 }, "regulatory": { "ind": 25, "nda-bla": 2, "expedited": 2 }, "quality": { "cgmp": 9, "cdmo": 4 }, "commercial": { "reimbursement": 1 }, "compliance": {}, "financial": { "egc": 16, "runway": 1, "dual-class": 15 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Total artificial heart systems through its SynCardia subsidiary", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "NYSE" ], "tickers": [ "PMI" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-09-02", "pricingAccession": "0001829126-25-006957", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006957/picardmedical_424b4.htm", "firstPublicFilingDate": "2024-08-23", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-04-01", "daysFirstPublicToPricing": 375, "s1Amendments": 7, "staffCommentLetters": 10, "issuerResponses": 17, "themes": { "clinical": {}, "regulatory": { "pma-denovo": 110, "eu-mdr": 74 }, "quality": { "cgmp": 4, "cdmo": 4, "qsr": 9, "inspection": 1, "recall": 16 }, "commercial": { "reimbursement": 47, "medicare": 25, "payer": 14, "sales-force": 5 }, "compliance": { "hipaa": 2, "anti-kickback": 3 }, "financial": { "going-concern": 2, "egc": 22, "dual-class": 18 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage therapies for schizophrenia and other neuropsychiatric diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "LBRX" ], "quarter": "2025-Q3", "quarterComplete": true, "pricingDate": "2025-09-12", "pricingAccession": "0001193125-25-201757", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525201757/d12080d424b4.htm", "firstPublicFilingDate": "2024-05-20", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-08-22", "daysFirstPublicToPricing": 480, "s1Amendments": 1, "staffCommentLetters": 4, "issuerResponses": 5, "themes": { "clinical": { "phase-1": 13, "phase-2": 105, "phase-3": 51, "pivotal": 12, "topline": 10, "clinical-hold": 4, "clinical-validation": 1 }, "regulatory": { "ind": 26, "nda-bla": 3, "expedited": 14 }, "quality": { "cgmp": 19, "cdmo": 25, "inspection": 3, "recall": 8 }, "commercial": { "reimbursement": 79, "medicare": 79, "payer": 54, "sales-force": 3 }, "compliance": { "hipaa": 7, "anti-kickback": 13 }, "financial": { "going-concern": 2, "material-weakness": 1, "egc": 33, "runway": 1, "dual-class": 6 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 8071, "sicDescription": "Services-Medical Laboratories", "sectorBasis": "SEC SIC 8071 (Services-Medical Laboratories); reassigned after reading the prospectus business description: the prospectus describes a precision molecular diagnostics company selling laboratory tests, so it is grouped with diagnostics rather than care delivery", "profile": "Molecular diagnostics lab tests in prenatal and oncology testing", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "BLLN" ], "quarter": "2025-Q4", "quarterComplete": true, "pricingDate": "2025-11-06", "pricingAccession": "0001193125-25-270155", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525270155/d903739d424b4.htm", "firstPublicFilingDate": "2025-06-20", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-10-07", "daysFirstPublicToPricing": 139, "s1Amendments": 1, "staffCommentLetters": 2, "issuerResponses": 0, "themes": { "clinical": { "phase-3": 10, "clinical-validation": 49 }, "regulatory": { "510k": 8, "pma-denovo": 35, "clia-ldt": 42 }, "quality": { "cgmp": 1, "qsr": 2, "inspection": 4, "recall": 8 }, "commercial": { "reimbursement": 143, "coding": 15, "medicare": 133, "payer": 168, "value-based": 1, "sales-force": 26 }, "compliance": { "hipaa": 30, "anti-kickback": 13, "stark": 12, "cpom": 2 }, "financial": { "material-weakness": 4, "egc": 22, "runway": 1, "dual-class": 76 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage therapies for chronic inflammatory diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "NYSE" ], "tickers": [ "EVMN" ], "quarter": "2025-Q4", "quarterComplete": true, "pricingDate": "2025-11-06", "pricingAccession": "0001193125-25-270066", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525270066/d771358d424b4.htm", "firstPublicFilingDate": "2025-05-14", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-10-09", "daysFirstPublicToPricing": 176, "s1Amendments": 1, "staffCommentLetters": 4, "issuerResponses": 1, "themes": { "clinical": { "phase-1": 40, "phase-2": 78, "phase-3": 11, "topline": 8, "clinical-hold": 3, "clinical-validation": 1 }, "regulatory": { "ind": 17, "nda-bla": 15, "expedited": 17 }, "quality": { "cgmp": 20, "cdmo": 30, "inspection": 3, "recall": 7 }, "commercial": { "reimbursement": 63, "medicare": 62, "payer": 54, "sales-force": 6 }, "compliance": { "hipaa": 11, "anti-kickback": 4 }, "financial": { "going-concern": 1, "egc": 11, "runway": 4 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "sectorLabel": "Healthcare services", "sic": 8090, "sicDescription": "Services-Misc Health & Allied Services, NEC", "sectorBasis": "SEC SIC 8090 (Services-Misc Health & Allied Services, NEC); prospectus business description read and consistent", "profile": "Dental support organization providing business services to affiliated practices", "offeringType": "underwritten IPO", "stateOfIncorporation": "MN", "exchanges": [ "Nasdaq" ], "tickers": [ "PARK" ], "quarter": "2025-Q4", "quarterComplete": true, "pricingDate": "2025-12-03", "pricingAccession": "0001104659-25-118023", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925118023/tm2514579-16_424b4.htm", "firstPublicFilingDate": "2025-05-21", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-09-03", "daysFirstPublicToPricing": 196, "s1Amendments": 2, "staffCommentLetters": 4, "issuerResponses": 7, "themes": { "clinical": {}, "regulatory": {}, "quality": { "recall": 1 }, "commercial": { "reimbursement": 33, "medicare": 36, "payer": 71 }, "compliance": { "hipaa": 8, "anti-kickback": 4, "stark": 1 }, "financial": { "egc": 17, "dual-class": 9 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "sectorLabel": "Healthcare services", "sic": 8071, "sicDescription": "Services-Medical Laboratories", "sectorBasis": "SEC SIC 8071 (Services-Medical Laboratories); prospectus business description read and consistent", "profile": "Outpatient diagnostic imaging centers", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "LMRI" ], "quarter": "2025-Q4", "quarterComplete": true, "pricingDate": "2025-12-12", "pricingAccession": "0001193125-25-316455", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525316455/d217676d424b4.htm", "firstPublicFilingDate": "2025-06-12", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-11-17", "daysFirstPublicToPricing": 183, "s1Amendments": 1, "staffCommentLetters": 4, "issuerResponses": 4, "themes": { "clinical": {}, "regulatory": {}, "quality": {}, "commercial": { "reimbursement": 62, "coding": 1, "medicare": 143, "payer": 169, "value-based": 1, "sales-force": 1 }, "compliance": { "hipaa": 22, "anti-kickback": 24, "stark": 22, "cpom": 8, "con": 6 }, "financial": { "material-weakness": 1, "egc": 18 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Medical-surgical products and supply chain services at scale", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "MDLN" ], "quarter": "2025-Q4", "quarterComplete": true, "pricingDate": "2025-12-18", "pricingAccession": "0001193125-25-323742", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525323742/d77351d424b4.htm", "firstPublicFilingDate": "2024-12-19", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-10-28", "daysFirstPublicToPricing": 364, "s1Amendments": 2, "staffCommentLetters": 2, "issuerResponses": 2, "themes": { "clinical": {}, "regulatory": { "ind": 3, "nda-bla": 1, "510k": 25, "pma-denovo": 10, "eu-mdr": 6 }, "quality": { "cgmp": 1, "cdmo": 4, "qsr": 2, "inspection": 5, "recall": 17 }, "commercial": { "reimbursement": 30, "medicare": 28, "payer": 15, "value-based": 1, "sales-force": 1 }, "compliance": { "hipaa": 16, "anti-kickback": 1, "stark": 6 }, "financial": { "dual-class": 137 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage targeted radiopharmaceuticals for oncology", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "AKTS" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-01-09", "pricingAccession": "0001193125-26-009078", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526009078/d875386d424b4.htm", "firstPublicFilingDate": "2024-10-11", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-12-19", "daysFirstPublicToPricing": 455, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 5, "phase-2": 6, "phase-3": 4, "pivotal": 5, "topline": 4, "clinical-hold": 7, "clinical-validation": 9 }, "regulatory": { "ind": 46, "nda-bla": 49, "expedited": 51 }, "quality": { "cgmp": 28, "cdmo": 41, "inspection": 3, "recall": 12 }, "commercial": { "reimbursement": 65, "medicare": 51, "payer": 50, "sales-force": 4 }, "compliance": { "hipaa": 17, "anti-kickback": 10 }, "financial": { "egc": 31, "runway": 4 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage therapies for rare pediatric lysosomal storage disorders", "offeringType": "direct listing", "stateOfIncorporation": "WY", "exchanges": [ "Nasdaq" ], "tickers": [ "PLYX" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-02-02", "pricingAccession": "0001213900-26-010761", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026010761/ea0251239-09.htm", "firstPublicFilingDate": "2025-08-05", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-11-21", "daysFirstPublicToPricing": 181, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 3, "phase-2": 23, "phase-3": 6, "pivotal": 13, "topline": 7, "clinical-hold": 6, "clinical-validation": 1 }, "regulatory": { "ind": 63, "nda-bla": 49, "expedited": 97 }, "quality": { "cgmp": 27, "cdmo": 31, "inspection": 3, "recall": 8 }, "commercial": { "reimbursement": 52, "medicare": 25, "payer": 26, "sales-force": 3 }, "compliance": { "hipaa": 14 }, "financial": { "egc": 24, "runway": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Late clinical-stage therapeutics for aesthetic and dermatological conditions", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "NYSE" ], "tickers": [ "MANE" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-02-04", "pricingAccession": "0001628280-26-005505", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026005505/veradermicsinc424b4.htm", "firstPublicFilingDate": "2025-10-27", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-01-09", "daysFirstPublicToPricing": 100, "s1Amendments": 1, "staffCommentLetters": 1, "issuerResponses": 2, "themes": { "clinical": { "phase-1": 13, "phase-2": 38, "phase-3": 26, "pivotal": 1, "topline": 12, "clinical-hold": 4 }, "regulatory": { "ind": 20, "nda-bla": 3 }, "quality": { "cgmp": 17, "cdmo": 38, "inspection": 3, "recall": 6 }, "commercial": { "reimbursement": 55, "medicare": 46, "payer": 52, "sales-force": 5 }, "compliance": { "hipaa": 3, "anti-kickback": 4, "cpom": 1 }, "financial": { "egc": 36, "runway": 3 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Late-stage clinical biopharmaceutical pipeline across several indications", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "EIKN" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-02-05", "pricingAccession": "0001193125-26-039375", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526039375/d99350d424b4.htm", "firstPublicFilingDate": "2025-05-09", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-01-09", "daysFirstPublicToPricing": 272, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 24, "phase-2": 45, "phase-3": 11, "pivotal": 14, "topline": 2, "clinical-hold": 13 }, "regulatory": { "ind": 38, "nda-bla": 40, "expedited": 32 }, "quality": { "cgmp": 20, "cdmo": 39, "inspection": 1, "recall": 10 }, "commercial": { "reimbursement": 73, "medicare": 68, "payer": 59, "sales-force": 4 }, "compliance": { "hipaa": 13, "anti-kickback": 10 }, "financial": { "material-weakness": 3, "egc": 32, "runway": 3 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); reassigned after reading the prospectus business description: the prospectus describes a late-stage biopharmaceutical company delivering approved medicines through sustained-release eye implants, so its evidence path is drug development", "profile": "Late-stage sustained-release drug delivery for chronic eye conditions", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "SGP" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-02-06", "pricingAccession": "0001628280-26-006068", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026006068/spyglass-424b4.htm", "firstPublicFilingDate": "2025-09-26", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-01-16", "daysFirstPublicToPricing": 133, "s1Amendments": 1, "staffCommentLetters": 3, "issuerResponses": 4, "themes": { "clinical": { "phase-1": 2, "phase-2": 2, "phase-3": 44, "pivotal": 1, "topline": 3, "clinical-hold": 4, "clinical-validation": 1 }, "regulatory": { "ind": 10, "nda-bla": 7, "expedited": 12, "510k": 2, "pma-denovo": 5, "eu-mdr": 1 }, "quality": { "cgmp": 21, "cdmo": 31, "qsr": 4, "inspection": 5, "recall": 9 }, "commercial": { "reimbursement": 82, "coding": 12, "medicare": 74, "payer": 40, "sales-force": 2 }, "compliance": { "hipaa": 6, "anti-kickback": 10 }, "financial": { "material-weakness": 1, "egc": 24, "runway": 4 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage generative-AI protein design and drug development", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "GENB" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-02-27", "pricingAccession": "0001193125-26-083190", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526083190/generate_bio_424b4.htm", "firstPublicFilingDate": "2025-12-23", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-02-04", "daysFirstPublicToPricing": 66, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 57, "phase-2": 14, "phase-3": 61, "pivotal": 5, "topline": 3, "clinical-hold": 6 }, "regulatory": { "ind": 42, "nda-bla": 55, "expedited": 37, "510k": 1 }, "quality": { "cgmp": 31, "cdmo": 65, "inspection": 5, "recall": 11 }, "commercial": { "reimbursement": 92, "medicare": 48, "payer": 53, "sales-force": 3 }, "compliance": { "hipaa": 8, "anti-kickback": 9 }, "financial": { "going-concern": 1, "egc": 24, "runway": 4 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Scaled diabetes management devices, a carve-out from a larger device company", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "MMED" ], "quarter": "2026-Q1", "quarterComplete": true, "pricingDate": "2026-03-06", "pricingAccession": "0001628280-26-015648", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026015648/minimedgroupinc424b4.htm", "firstPublicFilingDate": "2025-05-30", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-12-19", "daysFirstPublicToPricing": 280, "s1Amendments": 3, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "pivotal": 3, "topline": 2 }, "regulatory": { "510k": 24, "pma-denovo": 23, "eu-mdr": 65 }, "quality": { "cgmp": 1, "cdmo": 1, "qsr": 2, "inspection": 18, "recall": 37 }, "commercial": { "reimbursement": 66, "coding": 1, "medicare": 25, "payer": 47, "value-based": 1, "sales-force": 9 }, "compliance": { "hipaa": 13, "anti-kickback": 2 }, "financial": { "dual-class": 23 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3826, "sicDescription": "Laboratory Analytical Instruments", "sectorBasis": "SEC SIC 3826 (Laboratory Analytical Instruments); prospectus business description read and consistent", "profile": "Commercial-stage proteomics instruments and assays", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "ALMR" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-04-17", "pricingAccession": "0001193125-26-161647", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526161647/d39680d424b4.htm", "firstPublicFilingDate": "2026-01-09", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-03-27", "daysFirstPublicToPricing": 98, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "clinical-validation": 1 }, "regulatory": { "510k": 16, "pma-denovo": 26, "clia-ldt": 6, "eu-mdr": 19 }, "quality": { "cgmp": 1, "cdmo": 7, "qsr": 10, "inspection": 5, "recall": 8 }, "commercial": { "reimbursement": 7, "medicare": 5, "payer": 5, "sales-force": 3 }, "compliance": { "hipaa": 8, "anti-kickback": 2 }, "financial": { "egc": 29, "dual-class": 105 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage obesity therapeutics pipeline", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "KLRA" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-04-17", "pricingAccession": "0001193125-26-161521", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526161521/d113532d424b4.htm", "firstPublicFilingDate": "2025-12-19", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-03-27", "daysFirstPublicToPricing": 119, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 41, "phase-2": 55, "phase-3": 90, "pivotal": 1, "topline": 25, "clinical-hold": 12 }, "regulatory": { "ind": 19, "nda-bla": 29, "expedited": 9 }, "quality": { "cgmp": 22, "cdmo": 12, "inspection": 4, "recall": 8 }, "commercial": { "reimbursement": 73, "medicare": 58, "payer": 48, "sales-force": 3 }, "compliance": { "hipaa": 6, "anti-kickback": 7 }, "financial": { "egc": 36, "runway": 3 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Antimicrobial therapies for resistant pathogens", "offeringType": "direct listing", "stateOfIncorporation": "NV", "exchanges": [ "Nasdaq" ], "tickers": [ "LABT" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-04-23", "pricingAccession": "0001213900-26-047113", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026047113/ea0248668-15.htm", "firstPublicFilingDate": "2025-07-31", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-01-09", "daysFirstPublicToPricing": 266, "s1Amendments": 5, "staffCommentLetters": 1, "issuerResponses": 1, "themes": { "clinical": { "phase-1": 5, "phase-2": 6, "phase-3": 8, "topline": 1, "clinical-hold": 6 }, "regulatory": { "ind": 26, "nda-bla": 7, "expedited": 22 }, "quality": { "cgmp": 26, "cdmo": 10, "inspection": 1, "recall": 8 }, "commercial": { "reimbursement": 57, "medicare": 46, "payer": 54, "sales-force": 3 }, "compliance": { "hipaa": 20 }, "financial": { "going-concern": 7, "material-weakness": 1, "egc": 23 } }, "verified": "2026-09", "status": "verified", "gaps": [] }, { "id": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage inhaled therapies for rare respiratory diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "AVLN" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-04-30", "pricingAccession": "0001193125-26-197686", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/424b4.htm", "firstPublicFilingDate": "2026-02-06", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-04-08", "daysFirstPublicToPricing": 83, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 34, "phase-2": 31, "phase-3": 18, "pivotal": 7, "topline": 5, "clinical-hold": 10 }, "regulatory": { "ind": 48, "nda-bla": 3, "expedited": 61, "eu-mdr": 2 }, "quality": { "cgmp": 20, "cdmo": 25, "inspection": 5, "recall": 8 }, "commercial": { "reimbursement": 66, "medicare": 47, "payer": 46, "sales-force": 5 }, "compliance": { "hipaa": 6, "anti-kickback": 5 }, "financial": { "egc": 29, "runway": 3 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Clinical-stage therapies for blood coagulation disorders", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "COAG" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-05-01", "pricingAccession": "0001193125-26-201458", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526201458/d50309d424b4.htm", "firstPublicFilingDate": "2026-02-27", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-04-10", "daysFirstPublicToPricing": 63, "s1Amendments": 3, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 4, "phase-2": 35, "phase-3": 41, "pivotal": 17, "topline": 1, "clinical-hold": 13, "clinical-validation": 2 }, "regulatory": { "ind": 33, "nda-bla": 59, "expedited": 76 }, "quality": { "cgmp": 19, "cdmo": 14, "inspection": 2, "recall": 5 }, "commercial": { "reimbursement": 68, "medicare": 80, "payer": 30, "sales-force": 3 }, "compliance": { "hipaa": 14, "anti-kickback": 5 }, "financial": { "material-weakness": 5, "egc": 27, "runway": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage medicines for depression, anxiety and neuropsychiatric disorders", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "SPTX" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-05-01", "pricingAccession": "0001193125-26-201758", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526201758/d73463d424b4.htm", "firstPublicFilingDate": "2025-11-21", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-04-10", "daysFirstPublicToPricing": 161, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 39, "phase-2": 1, "phase-3": 11, "topline": 32, "clinical-hold": 13, "clinical-validation": 2 }, "regulatory": { "ind": 26, "nda-bla": 13, "expedited": 26 }, "quality": { "cgmp": 20, "cdmo": 19, "inspection": 2, "recall": 8 }, "commercial": { "reimbursement": 115, "medicare": 58, "payer": 72, "sales-force": 3 }, "compliance": { "hipaa": 3, "anti-kickback": 8 }, "financial": { "egc": 35, "runway": 2 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3841, "sicDescription": "Surgical & Medical Instruments & Apparatus", "sectorBasis": "SEC SIC 3841 (Surgical & Medical Instruments & Apparatus); prospectus business description read and consistent", "profile": "Commercial-stage device for stroke motor recovery", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "MOBI" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-05-08", "pricingAccession": "0001628280-26-032843", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026032843/mobiamedical-424b4.htm", "firstPublicFilingDate": "2026-01-21", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-04-17", "daysFirstPublicToPricing": 107, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "pivotal": 9, "clinical-hold": 1, "clinical-validation": 3 }, "regulatory": { "510k": 33, "pma-denovo": 88, "breakthrough-device": 15 }, "quality": { "cgmp": 2, "cdmo": 11, "qsr": 15, "inspection": 8, "recall": 39 }, "commercial": { "reimbursement": 68, "coding": 17, "medicare": 70, "payer": 106, "sales-force": 15 }, "compliance": { "hipaa": 15, "anti-kickback": 10 }, "financial": { "going-concern": 3, "material-weakness": 4, "egc": 32, "runway": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Clinical-stage therapies for autoimmune and inflammatory diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "ODTX" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-05-08", "pricingAccession": "0001193125-26-214819", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526214819/odyssey__form_424b4.htm", "firstPublicFilingDate": "2024-10-07", "firstPublicFilingForm": "DRS", "firstS1Date": "2025-01-17", "daysFirstPublicToPricing": 578, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 15, "phase-2": 17, "phase-3": 20, "pivotal": 4, "topline": 3, "clinical-hold": 8 }, "regulatory": { "ind": 55, "nda-bla": 43, "expedited": 30, "pma-denovo": 4 }, "quality": { "cgmp": 15, "cdmo": 38, "inspection": 1, "recall": 8 }, "commercial": { "reimbursement": 74, "medicare": 67, "payer": 59, "sales-force": 2 }, "compliance": { "hipaa": 8, "anti-kickback": 10 }, "financial": { "egc": 25, "runway": 3, "dual-class": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "sectorLabel": "Medical device and diagnostics", "sic": 3842, "sicDescription": "Orthopedic, Prosthetic & Surgical Appliances & Supplies", "sectorBasis": "SEC SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies); prospectus business description read and consistent", "profile": "Collagen-based regenerative tissue products", "offeringType": "direct listing", "stateOfIncorporation": "NV", "exchanges": [ "Nasdaq" ], "tickers": [ "CNXU" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-05-11", "pricingAccession": "0001062993-26-002473", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326002473/form424b4.htm", "firstPublicFilingDate": "2025-11-28", "firstPublicFilingForm": "S-1", "firstS1Date": "2025-11-28", "daysFirstPublicToPricing": 164, "s1Amendments": 6, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-2": 1, "pivotal": 3, "clinical-validation": 2 }, "regulatory": { "510k": 41, "pma-denovo": 52, "eu-mdr": 4 }, "quality": { "cgmp": 8, "cdmo": 36, "qsr": 3, "inspection": 3, "recall": 9 }, "commercial": { "reimbursement": 9, "coding": 1, "medicare": 6, "payer": 5, "sales-force": 1 }, "compliance": { "hipaa": 1, "anti-kickback": 1 }, "financial": { "going-concern": 1, "egc": 21 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage medicines against historically undruggable protein targets", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "PBLS" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-06-10", "pricingAccession": "0001193125-26-265983", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526265983/pbls_424b4.htm", "firstPublicFilingDate": "2026-04-02", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-05-19", "daysFirstPublicToPricing": 69, "s1Amendments": 3, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 4, "phase-2": 11, "phase-3": 29, "pivotal": 3, "topline": 3, "clinical-hold": 14, "clinical-validation": 3 }, "regulatory": { "ind": 36, "nda-bla": 4, "expedited": 54 }, "quality": { "cgmp": 30, "cdmo": 68, "inspection": 4, "recall": 10 }, "commercial": { "reimbursement": 84, "medicare": 51, "payer": 50, "sales-force": 1 }, "compliance": { "hipaa": 6, "anti-kickback": 8 }, "financial": { "egc": 21, "runway": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage precision therapeutics for cardiovascular disease", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "KARD" ], "quarter": "2026-Q2", "quarterComplete": true, "pricingDate": "2026-06-18", "pricingAccession": "0001193125-26-276096", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526276096/d107928d424b4.htm", "firstPublicFilingDate": "2026-03-26", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-05-26", "daysFirstPublicToPricing": 84, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 7, "phase-2": 68, "phase-3": 57, "pivotal": 2, "topline": 13, "clinical-hold": 14 }, "regulatory": { "ind": 29, "nda-bla": 7, "expedited": 59, "510k": 32, "pma-denovo": 17, "eu-mdr": 10 }, "quality": { "cgmp": 27, "cdmo": 33, "qsr": 3, "inspection": 8, "recall": 20 }, "commercial": { "reimbursement": 121, "medicare": 55, "payer": 78, "sales-force": 6 }, "compliance": { "hipaa": 12, "anti-kickback": 9 }, "financial": { "going-concern": 1, "egc": 38, "runway": 2 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Clinical-stage in vivo CRISPR genome-editing therapies", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "SCTX" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-07-27", "pricingAccession": "0001193125-26-316503", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526316503/d21355d424b4.htm", "firstPublicFilingDate": "2026-01-09", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-02", "daysFirstPublicToPricing": 199, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 10, "phase-2": 3, "phase-3": 2, "pivotal": 1, "topline": 2, "clinical-hold": 4 }, "regulatory": { "ind": 21, "nda-bla": 61, "expedited": 51 }, "quality": { "cgmp": 17, "cdmo": 27, "inspection": 1, "recall": 12 }, "commercial": { "reimbursement": 30, "medicare": 41, "payer": 30, "sales-force": 3 }, "compliance": { "hipaa": 2, "anti-kickback": 11 }, "financial": { "egc": 34, "runway": 1 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Late-stage oral therapies for obstructive sleep apnea and related breathing disorders", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "APMD" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-07-31", "pricingAccession": "0001193125-26-328422", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526328422/apmd_424b4.htm", "firstPublicFilingDate": "2024-07-01", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-10", "daysFirstPublicToPricing": 760, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 9, "phase-2": 10, "phase-3": 55, "topline": 5, "clinical-hold": 3 }, "regulatory": { "ind": 28, "nda-bla": 5, "expedited": 44 }, "quality": { "cgmp": 19, "cdmo": 52, "inspection": 8, "recall": 9 }, "commercial": { "reimbursement": 78, "medicare": 61, "payer": 89, "sales-force": 8 }, "compliance": { "hipaa": 16, "anti-kickback": 3 }, "financial": { "material-weakness": 1, "egc": 27, "runway": 2, "dual-class": 59 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Clinical-stage biotherapeutics for immune-mediated diseases", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "ATTO" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-08-05", "pricingAccession": "0001193125-26-334997", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526334997/d40469d424b4.htm", "firstPublicFilingDate": "2025-12-19", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-14", "daysFirstPublicToPricing": 229, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 48, "phase-2": 15, "phase-3": 12, "topline": 4, "clinical-hold": 7, "clinical-validation": 1 }, "regulatory": { "ind": 35, "nda-bla": 47, "expedited": 9 }, "quality": { "cgmp": 16, "cdmo": 36, "inspection": 4, "recall": 7 }, "commercial": { "reimbursement": 66, "medicare": 54, "payer": 45, "sales-force": 3 }, "compliance": { "hipaa": 11, "anti-kickback": 10 }, "financial": { "egc": 26 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage therapies for hypertrophic cardiomyopathy", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "BRVE" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-08-06", "pricingAccession": "0001628280-26-054354", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026054354/braveheartbioinc-sx1a2.htm", "firstPublicFilingDate": "2026-04-29", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-15", "daysFirstPublicToPricing": 99, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 20, "phase-2": 77, "phase-3": 110, "pivotal": 7, "topline": 3, "clinical-hold": 9, "clinical-validation": 1 }, "regulatory": { "ind": 35, "nda-bla": 7, "expedited": 58 }, "quality": { "cgmp": 20, "cdmo": 18, "inspection": 5, "recall": 10 }, "commercial": { "reimbursement": 68, "medicare": 49, "payer": 45, "sales-force": 4 }, "compliance": { "hipaa": 5, "anti-kickback": 6 }, "financial": { "egc": 31, "runway": 2 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage small-molecule cancer therapeutics", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "BLSM" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-08-07", "pricingAccession": "0001193125-26-340215", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526340215/d98958d424b4.htm", "firstPublicFilingDate": "2026-04-24", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-17", "daysFirstPublicToPricing": 105, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 63, "phase-2": 23, "phase-3": 6, "pivotal": 1, "topline": 1, "clinical-hold": 4, "clinical-validation": 2 }, "regulatory": { "ind": 45, "nda-bla": 7, "expedited": 38, "pma-denovo": 1 }, "quality": { "cgmp": 20, "cdmo": 11, "inspection": 4, "recall": 7 }, "commercial": { "reimbursement": 62, "medicare": 57, "payer": 46, "sales-force": 5 }, "compliance": { "hipaa": 9, "anti-kickback": 13 }, "financial": { "going-concern": 3, "egc": 39 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage non-opioid pain medicines", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "LTGO" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-08-07", "pricingAccession": "0001193125-26-340329", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526340329/d38775d424b4.htm", "firstPublicFilingDate": "2026-03-27", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-17", "daysFirstPublicToPricing": 133, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 33, "phase-2": 28, "phase-3": 39, "pivotal": 9, "topline": 16, "clinical-hold": 7, "clinical-validation": 2 }, "regulatory": { "ind": 22, "nda-bla": 8, "expedited": 23 }, "quality": { "cgmp": 20, "cdmo": 18, "inspection": 5, "recall": 8 }, "commercial": { "reimbursement": 60, "coding": 39, "medicare": 56, "payer": 50, "sales-force": 7 }, "compliance": { "hipaa": 10, "anti-kickback": 13 }, "financial": { "going-concern": 4, "material-weakness": 3, "egc": 33 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2834, "sicDescription": "Pharmaceutical Preparations", "sectorBasis": "SEC SIC 2834 (Pharmaceutical Preparations); prospectus business description read and consistent", "profile": "Clinical-stage therapies for metabolic disorders, including post-bariatric hypoglycemia", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "VOGX" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-08-12", "pricingAccession": "0001185185-26-003448", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003448/vogenx424b4081126.htm", "firstPublicFilingDate": "2026-02-20", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-07-15", "daysFirstPublicToPricing": 173, "s1Amendments": 2, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 12, "phase-2": 32, "phase-3": 10, "pivotal": 2, "topline": 2, "clinical-hold": 14 }, "regulatory": { "ind": 34, "nda-bla": 9, "expedited": 43 }, "quality": { "cgmp": 19, "cdmo": 19, "inspection": 2, "recall": 6 }, "commercial": { "reimbursement": 98, "medicare": 45, "payer": 61, "sales-force": 5 }, "compliance": { "hipaa": 8, "anti-kickback": 5 }, "financial": { "going-concern": 1, "material-weakness": 2, "egc": 31, "runway": 2 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] }, { "id": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "sectorLabel": "Biotech and pharma", "sic": 2836, "sicDescription": "Biological Products, (No Diagnostic Substances)", "sectorBasis": "SEC SIC 2836 (Biological Products, (No Diagnostic Substances)); prospectus business description read and consistent", "profile": "Late clinical-stage precision medicines for immune-mediated diseases and cancer", "offeringType": "underwritten IPO", "stateOfIncorporation": "DE", "exchanges": [ "Nasdaq" ], "tickers": [ "ETRA" ], "quarter": "2026-Q3", "quarterComplete": false, "pricingDate": "2026-09-18", "pricingAccession": "0001193125-26-395670", "prospectusUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/d61940d424b4.htm", "firstPublicFilingDate": "2026-06-26", "firstPublicFilingForm": "DRS", "firstS1Date": "2026-08-28", "daysFirstPublicToPricing": 84, "s1Amendments": 1, "staffCommentLetters": 0, "issuerResponses": 0, "themes": { "clinical": { "phase-1": 37, "phase-2": 2, "phase-3": 3, "topline": 6, "clinical-hold": 5, "clinical-validation": 2 }, "regulatory": { "ind": 28, "nda-bla": 74, "expedited": 62 }, "quality": { "cgmp": 22, "cdmo": 45, "inspection": 4, "recall": 8 }, "commercial": { "reimbursement": 74, "medicare": 51, "payer": 49, "sales-force": 3 }, "compliance": { "hipaa": 13, "anti-kickback": 10 }, "financial": { "going-concern": 4, "egc": 31, "runway": 2 } }, "verified": "2026-09", "status": "verified", "gaps": [ "No SEC staff comment letters released on EDGAR as of collection" ] } ], "filings": [ { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "DRS", "eventDate": "2024-05-20", "accession": "0000950123-24-005777", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012324005777/0000950123-24-005777-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012324005777/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-06-17", "accession": "0000000000-24-006957", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000024006957/0000000000-24-006957-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000024006957/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "DRS", "eventDate": "2024-06-20", "accession": "0001493152-24-024532", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224024532/0001493152-24-024532-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224024532/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-06-24", "accession": "0000950123-24-006300", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012324006300/0000950123-24-006300-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012324006300/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "DRS", "eventDate": "2024-07-01", "accession": "0000950123-24-006348", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000095012324006348/0000950123-24-006348-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000095012324006348/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-07-02", "accession": "0000000000-24-007549", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000024007549/0000000000-24-007549-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000024007549/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-07-17", "accession": "0000000000-24-008116", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024008116/0000000000-24-008116-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024008116/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-08-15", "accession": "0001493152-24-032472", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224032472/0001493152-24-032472-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224032472/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "DRS", "eventDate": "2024-08-23", "accession": "0001829126-24-005814", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624005814/0001829126-24-005814-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624005814/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-08-28", "accession": "0000000000-24-009821", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024009821/0000000000-24-009821-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024009821/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-09-16", "accession": "0001493152-24-036252", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224036252/0001493152-24-036252-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224036252/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-09-23", "accession": "0000000000-24-010778", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024010778/0000000000-24-010778-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024010778/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS", "eventDate": "2024-10-07", "accession": "0000950123-24-009534", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324009534/0000950123-24-009534-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324009534/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "DRS", "eventDate": "2024-10-11", "accession": "0000950123-24-009664", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324009664/0000950123-24-009664-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324009664/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2024-10-16", "accession": "0001493152-24-041337", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224041337/0001493152-24-041337-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224041337/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1", "eventDate": "2024-10-16", "accession": "0001493152-24-041335", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224041335/0001493152-24-041335-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224041335/forms-1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "UPLOAD", "eventDate": "2024-10-28", "accession": "0000000000-24-012014", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024012014/0000000000-24-012014-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000024012014/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2024-11-01", "accession": "0001493152-24-043387", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224043387/0001493152-24-043387-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224043387/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2024-11-01", "accession": "0001493152-24-043386", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224043386/0001493152-24-043386-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224043386/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "DRS/A", "eventDate": "2024-11-12", "accession": "0001829126-24-007436", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624007436/0001829126-24-007436-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624007436/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-11-18", "accession": "0000950123-24-012003", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324012003/0000950123-24-012003-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324012003/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-11-22", "accession": "0000950123-24-012069", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324012069/0000950123-24-012069-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324012069/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2024-11-27", "accession": "0001493152-24-048072", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224048072/0001493152-24-048072-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315224048072/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-12-05", "accession": "0000950123-24-012178", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324012178/0000950123-24-012178-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000095012324012178/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2024-12-10", "accession": "0000000000-24-013620", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000024013620/0000000000-24-013620-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000024013620/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "DRS/A", "eventDate": "2024-12-13", "accession": "0000950123-24-012257", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324012257/0000950123-24-012257-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012324012257/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "DRS", "eventDate": "2024-12-19", "accession": "0000950123-24-012281", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012324012281/0000950123-24-012281-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012324012281/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2024-12-26", "accession": "0001829126-24-008521", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624008521/0001829126-24-008521-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624008521/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "DRS/A", "eventDate": "2024-12-26", "accession": "0001829126-24-008520", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624008520/0001829126-24-008520-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912624008520/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-01-14", "accession": "0000000000-25-000410", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025000410/0000000000-25-000410-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025000410/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "S-1", "eventDate": "2025-01-17", "accession": "0001193125-25-008362", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312525008362/0001193125-25-008362-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312525008362/d818486ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-01-23", "accession": "0001829126-25-000343", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625000343/0001829126-25-000343-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625000343/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "DRS/A", "eventDate": "2025-01-24", "accession": "0001829126-25-000342", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625000342/0001829126-25-000342-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625000342/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "DRS/A", "eventDate": "2025-01-31", "accession": "0000950123-25-000784", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325000784/0000950123-25-000784-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325000784/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "DRS", "eventDate": "2025-02-06", "accession": "0001628280-25-004179", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025004179/0001628280-25-004179-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025004179/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "DRS", "eventDate": "2025-02-07", "accession": "0000950123-25-001205", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000095012325001205/0000950123-25-001205-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000095012325001205/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-02-07", "accession": "0000000000-25-001348", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025001348/0000000000-25-001348-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025001348/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-02-14", "accession": "0001493152-25-006655", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225006655/0001493152-25-006655-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225006655/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-02-21", "accession": "0000000000-25-002048", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000025002048/0000000000-25-002048-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000000000025002048/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "DRS/A", "eventDate": "2025-02-28", "accession": "0000950123-25-002928", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325002928/0000950123-25-002928-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325002928/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "UPLOAD", "eventDate": "2025-03-05", "accession": "0000000000-25-002464", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025002464/0000000000-25-002464-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025002464/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "UPLOAD", "eventDate": "2025-03-10", "accession": "0000000000-25-002580", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000025002580/0000000000-25-002580-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000025002580/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "DRS/A", "eventDate": "2025-03-14", "accession": "0000950123-25-003072", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000095012325003072/0000950123-25-003072-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000095012325003072/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-03-17", "accession": "0001493152-25-010522", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225010522/0001493152-25-010522-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225010522/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-03-17", "accession": "0001493152-25-010520", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225010520/0001493152-25-010520-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225010520/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "DRS/A", "eventDate": "2025-03-19", "accession": "0000950123-25-003112", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325003112/0000950123-25-003112-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325003112/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "DRS/A", "eventDate": "2025-03-27", "accession": "0001628279-25-000162", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000162/0001628279-25-000162-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000162/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "UPLOAD", "eventDate": "2025-03-28", "accession": "0000000000-25-003363", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000025003363/0000000000-25-003363-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000025003363/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-03-31", "accession": "0001829126-25-002254", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002254/0001829126-25-002254-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002254/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1", "eventDate": "2025-04-01", "accession": "0001829126-25-002253", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002253/0001829126-25-002253-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002253/picardmedical_s1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-04-08", "accession": "0001641172-25-003150", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003150/0001641172-25-003150-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003150/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-04-08", "accession": "0001641172-25-003130", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003130/0001641172-25-003130-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003130/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-04-09", "accession": "0001641172-25-003441", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003441/0001641172-25-003441-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225003441/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "UPLOAD", "eventDate": "2025-04-10", "accession": "0000000000-25-003854", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025003854/0000000000-25-003854-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025003854/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-04-14", "accession": "0000000000-25-003941", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025003941/0000000000-25-003941-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025003941/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "DRS", "eventDate": "2025-04-17", "accession": "0001628279-25-000227", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162827925000227/0001628279-25-000227-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162827925000227/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "DRS/A", "eventDate": "2025-04-18", "accession": "0001628279-25-000230", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000230/0001628279-25-000230-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000230/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "DRS", "eventDate": "2025-04-24", "accession": "0000950123-25-003656", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325003656/0000950123-25-003656-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325003656/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-04-24", "accession": "0001829126-25-002910", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002910/0001829126-25-002910-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002910/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-04-25", "accession": "0001829126-25-002912", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002912/0001829126-25-002912-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625002912/picardmedical_s1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "UPLOAD", "eventDate": "2025-04-28", "accession": "0000000000-25-004479", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025004479/0000000000-25-004479-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025004479/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-05-05", "accession": "0000000000-25-004748", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025004748/0000000000-25-004748-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025004748/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "CORRESP", "eventDate": "2025-05-09", "accession": "0001193125-25-116896", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525116896/0001193125-25-116896-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525116896/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "S-1", "eventDate": "2025-05-09", "accession": "0001193125-25-116894", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525116894/0001193125-25-116894-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525116894/d916440ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "DRS", "eventDate": "2025-05-09", "accession": "0000950123-25-004458", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000095012325004458/0000950123-25-004458-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000095012325004458/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-05-09", "accession": "0001829126-25-003509", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003509/0001829126-25-003509-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003509/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-05-09", "accession": "0001829126-25-003510", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003510/0001829126-25-003510-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003510/picardmedical_s1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "DRS", "eventDate": "2025-05-14", "accession": "0000950123-25-005244", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325005244/0000950123-25-005244-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325005244/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "UPLOAD", "eventDate": "2025-05-15", "accession": "0000000000-25-005184", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025005184/0000000000-25-005184-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025005184/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-05-19", "accession": "0000000000-25-005282", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025005282/0000000000-25-005282-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025005282/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "UPLOAD", "eventDate": "2025-05-21", "accession": "0000000000-25-005449", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000000000025005449/0000000000-25-005449-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000000000025005449/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "DRS", "eventDate": "2025-05-21", "accession": "0001104659-25-051659", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925051659/0001104659-25-051659-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925051659/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-05-22", "accession": "0000950123-25-005856", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012325005856/0000950123-25-005856-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000095012325005856/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-05-23", "accession": "0001829126-25-003921", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003921/0001829126-25-003921-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003921/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-05-23", "accession": "0001829126-25-003920", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003920/0001829126-25-003920-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625003920/picardmedical_s1a3.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "DRS/A", "eventDate": "2025-05-23", "accession": "0001628280-25-027560", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025027560/0001628280-25-027560-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025027560/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "S-1/A", "eventDate": "2025-05-30", "accession": "0001193125-25-132293", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525132293/0001193125-25-132293-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525132293/d916440ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "DRS/A", "eventDate": "2025-05-30", "accession": "0000950123-25-005939", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325005939/0000950123-25-005939-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325005939/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "DRS", "eventDate": "2025-05-30", "accession": "0001628280-25-028429", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025028429/0001628280-25-028429-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025028429/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "RW", "eventDate": "2025-06-09", "accession": "0001193125-25-137861", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312525137861/0001193125-25-137861-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312525137861/d818486drw.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "UPLOAD", "eventDate": "2025-06-09", "accession": "0000000000-25-006055", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025006055/0000000000-25-006055-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025006055/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-06-10", "accession": "0000000000-25-006098", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025006098/0000000000-25-006098-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025006098/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "DRS", "eventDate": "2025-06-12", "accession": "0000950123-25-006005", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325006005/0000950123-25-006005-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325006005/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "S-1/A", "eventDate": "2025-06-13", "accession": "0001193125-25-140836", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525140836/0001193125-25-140836-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525140836/d916440ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "UPLOAD", "eventDate": "2025-06-17", "accession": "0000000000-25-006355", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000000000025006355/0000000000-25-006355-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000000000025006355/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "UPLOAD", "eventDate": "2025-06-18", "accession": "0000000000-25-006446", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025006446/0000000000-25-006446-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025006446/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "DRS/A", "eventDate": "2025-06-18", "accession": "0001628280-25-032169", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025032169/0001628280-25-032169-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025032169/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "DRS", "eventDate": "2025-06-20", "accession": "0000950123-25-006095", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000095012325006095/0000950123-25-006095-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000095012325006095/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "DRS/A", "eventDate": "2025-06-23", "accession": "0001628279-25-000389", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000389/0001628279-25-000389-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162827925000389/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "CORRESP", "eventDate": "2025-06-26", "accession": "0000950170-25-090242", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025090242/0000950170-25-090242-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025090242/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "S-1", "eventDate": "2025-06-26", "accession": "0000950123-25-006117", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325006117/0000950123-25-006117-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095012325006117/carl_-_s-1_-_june_2025.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "S-1/A", "eventDate": "2025-06-27", "accession": "0001193125-25-149285", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525149285/0001193125-25-149285-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525149285/d916440ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "CORRESP", "eventDate": "2025-06-30", "accession": "0001193125-25-152538", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525152538/0001193125-25-152538-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525152538/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "CORRESP", "eventDate": "2025-06-30", "accession": "0001193125-25-152510", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525152510/0001193125-25-152510-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525152510/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-07-01", "accession": "0001641172-25-017373", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225017373/0001641172-25-017373-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225017373/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-07-01", "accession": "0000950123-25-006156", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000095012325006156/0000950123-25-006156-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000095012325006156/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "424B4", "eventDate": "2025-07-03", "accession": "0001193125-25-155088", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525155088/0001193125-25-155088-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000119312525155088/d916440d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "UPLOAD", "eventDate": "2025-07-03", "accession": "0000000000-25-007042", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025007042/0000000000-25-007042-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025007042/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-07", "accession": "0000950170-25-094134", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025094134/0000950170-25-094134-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025094134/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "S-1", "eventDate": "2025-07-07", "accession": "0001628280-25-034437", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034437/0001628280-25-034437-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034437/shoulderinnovation-sx1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "UPLOAD", "eventDate": "2025-07-09", "accession": "0000000000-25-007245", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025007245/0000000000-25-007245-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025007245/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-09", "accession": "0001628280-25-034670", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034670/0001628280-25-034670-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034670/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-09", "accession": "0001628280-25-034668", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034668/0001628280-25-034668-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025034668/shoulderinnovation-sx1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-14", "accession": "0001829126-25-005032", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005032/0001829126-25-005032-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005032/picardmedical_s1a4.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-15", "accession": "0000950170-25-095712", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025095712/0000950170-25-095712-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025095712/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-15", "accession": "0000950170-25-095710", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025095710/0000950170-25-095710-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025095710/carl_-_s-1a_1_-_july_202.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "UPLOAD", "eventDate": "2025-07-17", "accession": "0000000000-25-007567", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000000000025007567/0000000000-25-007567-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000000000025007567/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "S-1", "eventDate": "2025-07-17", "accession": "0001628280-25-035242", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025035242/0001628280-25-035242-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025035242/heartflowinc-sx1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-18", "accession": "0000950170-25-096880", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025096880/0000950170-25-096880-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025096880/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-18", "accession": "0000950170-25-096878", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025096878/0000950170-25-096878-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025096878/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-07-18", "accession": "0001641172-25-020262", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225020262/0001641172-25-020262-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000164117225020262/forms-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-07-18", "accession": "0000950123-25-006472", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325006472/0000950123-25-006472-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325006472/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-18", "accession": "0001829126-25-005164", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005164/0001829126-25-005164-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005164/picardmedical_s1a5.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-07-23", "accession": "0000950123-25-006557", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012325006557/0000950123-25-006557-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000095012325006557/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-94546", "company": "CARLSMED, INC.", "cik": 1794546, "sector": "device", "form": "424B4", "eventDate": "2025-07-24", "accession": "0000950170-25-098125", "secUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025098125/0000950170-25-098125-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1794546/000095017025098125/carl_-_424b4_-_july_2025.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-24", "accession": "0001628280-25-035833", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025035833/0001628280-25-035833-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025035833/shoulderinnovation-sx1a2.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "UPLOAD", "eventDate": "2025-07-24", "accession": "0000000000-25-007800", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025007800/0000000000-25-007800-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000000000025007800/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2025-07-25", "accession": "0000000000-25-007855", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025007855/0000000000-25-007855-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000025007855/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-25", "accession": "0001628280-25-036021", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036021/0001628280-25-036021-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036021/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-25", "accession": "0001628280-25-036019", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036019/0001628280-25-036019-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036019/shoulderinnovation-sx1a3.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-28", "accession": "0001628280-25-036237", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036237/0001628280-25-036237-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036237/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-28", "accession": "0001628280-25-036179", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036179/0001628280-25-036179-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036179/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-28", "accession": "0001628280-25-036177", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036177/0001628280-25-036177-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025036177/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "DRS/A", "eventDate": "2025-07-29", "accession": "0001104659-25-071273", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925071273/0001104659-25-071273-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925071273/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-07-30", "accession": "0000000000-25-008014", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025008014/0000000000-25-008014-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025008014/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-07-30", "accession": "0001829126-25-005569", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005569/0001829126-25-005569-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005569/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-07-30", "accession": "0001829126-25-005568", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005568/0001829126-25-005568-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005568/picardmedical_s1a6.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "DRS", "eventDate": "2025-07-31", "accession": "0001213900-25-070092", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390025070092/0001213900-25-070092-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390025070092/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "S-1/A", "eventDate": "2025-08-01", "accession": "0001628280-25-037144", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037144/0001628280-25-037144-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037144/heartflowinc-sx1a1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-99350", "company": "SHOULDER INNOVATIONS, INC.", "cik": 1699350, "sector": "device", "form": "424B4", "eventDate": "2025-08-01", "accession": "0001628280-25-037109", "secUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025037109/0001628280-25-037109-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1699350/000162828025037109/shoulderinnovation-final42.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "CORRESP", "eventDate": "2025-08-05", "accession": "0001628280-25-037959", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037959/0001628280-25-037959-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037959/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "CORRESP", "eventDate": "2025-08-05", "accession": "0001628280-25-037956", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037956/0001628280-25-037956-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025037956/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "UPLOAD", "eventDate": "2025-08-05", "accession": "0000000000-25-008214", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025008214/0000000000-25-008214-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000000000025008214/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "DRS", "eventDate": "2025-08-05", "accession": "0001213900-25-072048", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025072048/0001213900-25-072048-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025072048/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "CORRESP", "eventDate": "2025-08-06", "accession": "0001628280-25-038093", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025038093/0001628280-25-038093-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025038093/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "S-1/A", "eventDate": "2025-08-06", "accession": "0001628280-25-038091", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025038091/0001628280-25-038091-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025038091/heartflowinc-sx1a2.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "S-1/A", "eventDate": "2025-08-06", "accession": "0001829126-25-005862", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005862/0001829126-25-005862-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625005862/picardmedical_s1a7.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "DRS/A", "eventDate": "2025-08-07", "accession": "0000950123-25-007241", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325007241/0000950123-25-007241-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325007241/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-08-08", "accession": "0001493152-25-011767", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225011767/0001493152-25-011767-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225011767/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-08-08", "accession": "0001493152-25-011762", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225011762/0001493152-25-011762-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225011762/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-64521", "company": "Heartflow, Inc.", "cik": 1464521, "sector": "device", "form": "424B4", "eventDate": "2025-08-08", "accession": "0001628280-25-039265", "secUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025039265/0001628280-25-039265-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1464521/000162828025039265/heartflowinc-424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-08-08", "accession": "0001829126-25-006012", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006012/0001829126-25-006012-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006012/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2025-08-08", "accession": "0001829126-25-006011", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006011/0001829126-25-006011-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006011/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "DRS/A", "eventDate": "2025-08-11", "accession": "0000950123-25-007483", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000095012325007483/0000950123-25-007483-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000095012325007483/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-08-12", "accession": "0000000000-25-008434", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000025008434/0000000000-25-008434-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000025008434/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "UPLOAD", "eventDate": "2025-08-12", "accession": "0000000000-25-008465", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025008465/0000000000-25-008465-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025008465/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "DRS/A", "eventDate": "2025-08-15", "accession": "0000950123-25-008500", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325008500/0000950123-25-008500-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000095012325008500/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-08-22", "accession": "0001193125-25-186474", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525186474/0001193125-25-186474-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525186474/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "S-1", "eventDate": "2025-08-22", "accession": "0001193125-25-186467", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525186467/0001193125-25-186467-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525186467/d12080ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "UPLOAD", "eventDate": "2025-08-22", "accession": "0000000000-25-009022", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025009022/0000000000-25-009022-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025009022/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "UPLOAD", "eventDate": "2025-08-26", "accession": "0000000000-25-009093", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000000000025009093/0000000000-25-009093-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000000000025009093/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "424B4", "eventDate": "2025-08-26", "accession": "0001493152-25-012351", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225012351/0001493152-25-012351-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225012351/form424b4.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-25942", "company": "Curanex Pharmaceuticals Inc", "cik": 2025942, "sector": "biotech", "form": "424B4", "eventDate": "2025-08-26", "accession": "0001493152-25-012350", "secUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225012350/0001493152-25-012350-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2025942/000149315225012350/form424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "DRS/A", "eventDate": "2025-08-27", "accession": "0001628280-25-041182", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025041182/0001628280-25-041182-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025041182/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-09-02", "accession": "0000950123-25-008631", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325008631/0000950123-25-008631-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000095012325008631/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "424B4", "eventDate": "2025-09-02", "accession": "0001829126-25-006957", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006957/0001829126-25-006957-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912625006957/picardmedical_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-09-03", "accession": "0001193125-25-195145", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525195145/0001193125-25-195145-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525195145/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-09-03", "accession": "0001104659-25-086773", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925086773/0001104659-25-086773-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925086773/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "S-1", "eventDate": "2025-09-03", "accession": "0001104659-25-086768", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925086768/0001104659-25-086768-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925086768/tm2514579-4_s1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-09-08", "accession": "0001193125-25-197877", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525197877/0001193125-25-197877-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525197877/d12080ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-09-09", "accession": "0001193125-25-198853", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525198853/0001193125-25-198853-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525198853/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "CORRESP", "eventDate": "2025-09-09", "accession": "0001193125-25-198852", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525198852/0001193125-25-198852-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525198852/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-09-10", "accession": "0000000000-25-009825", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025009825/0000000000-25-009825-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000025009825/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "S-1MEF", "eventDate": "2025-09-10", "accession": "0001193125-25-200422", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525200422/0001193125-25-200422-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525200422/d925823ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "424B4", "eventDate": "2025-09-12", "accession": "0001193125-25-201757", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525201757/0001193125-25-201757-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312525201757/d12080d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "DRS/A", "eventDate": "2025-09-12", "accession": "0000950123-25-008708", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325008708/0000950123-25-008708-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000095012325008708/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "DRS/A", "eventDate": "2025-09-17", "accession": "0001193125-25-206347", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525206347/0001193125-25-206347-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525206347/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "UPLOAD", "eventDate": "2025-09-17", "accession": "0000000000-25-010136", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025010136/0000000000-25-010136-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025010136/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-09-19", "accession": "0001213900-25-089144", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025089144/0001213900-25-089144-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025089144/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-09-23", "accession": "0001193125-25-211895", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525211895/0001193125-25-211895-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525211895/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-09-24", "accession": "0001104659-25-093000", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925093000/0001104659-25-093000-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925093000/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "S-1/A", "eventDate": "2025-09-24", "accession": "0001104659-25-092996", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925092996/0001104659-25-092996-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925092996/tm2514579-7_s1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-09-26", "accession": "0001193125-25-220186", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312525220186/0001193125-25-220186-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312525220186/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "UPLOAD", "eventDate": "2025-09-26", "accession": "0000000000-25-010542", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025010542/0000000000-25-010542-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025010542/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "DRS", "eventDate": "2025-09-26", "accession": "0001628279-25-000653", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162827925000653/0001628279-25-000653-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162827925000653/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "S-1", "eventDate": "2025-10-07", "accession": "0001193125-25-233697", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525233697/0001193125-25-233697-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525233697/d903739ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "S-1", "eventDate": "2025-10-09", "accession": "0001193125-25-235673", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525235673/0001193125-25-235673-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525235673/d771358ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "DRS/A", "eventDate": "2025-10-10", "accession": "0001193125-25-237018", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525237018/0001193125-25-237018-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525237018/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "S-1/A", "eventDate": "2025-10-17", "accession": "0001193125-25-242632", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525242632/0001193125-25-242632-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525242632/d903739ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "S-1/A", "eventDate": "2025-10-17", "accession": "0001193125-25-242492", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525242492/0001193125-25-242492-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525242492/d771358ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-10-17", "accession": "0001213900-25-100021", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390025100021/0001213900-25-100021-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390025100021/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "DRS", "eventDate": "2025-10-27", "accession": "0001628279-25-000707", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162827925000707/0001628279-25-000707-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162827925000707/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "S-1", "eventDate": "2025-10-28", "accession": "0001193125-25-253020", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525253020/0001193125-25-253020-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525253020/d932091ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "DRS/A", "eventDate": "2025-10-28", "accession": "0001628280-25-046655", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025046655/0001628280-25-046655-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025046655/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "S-1/A", "eventDate": "2025-11-04", "accession": "0001193125-25-264798", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525264798/0001193125-25-264798-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525264798/d55108ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-70849", "company": "BillionToOne, Inc.", "cik": 2070849, "sector": "device", "form": "424B4", "eventDate": "2025-11-06", "accession": "0001193125-25-270155", "secUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525270155/0001193125-25-270155-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2070849/000119312525270155/d903739d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "424B4", "eventDate": "2025-11-06", "accession": "0001193125-25-270066", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525270066/0001193125-25-270066-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312525270066/d771358d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-11-14", "accession": "0001193125-25-282912", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312525282912/0001193125-25-282912-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312525282912/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "UPLOAD", "eventDate": "2025-11-14", "accession": "0000000000-25-010785", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025010785/0000000000-25-010785-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000000000025010785/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "S-1", "eventDate": "2025-11-17", "accession": "0001193125-25-284663", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525284663/0001193125-25-284663-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525284663/d217676ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-18", "accession": "0001104659-25-113765", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925113765/0001104659-25-113765-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925113765/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "S-1/A", "eventDate": "2025-11-18", "accession": "0001104659-25-113757", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925113757/0001104659-25-113757-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925113757/tm2514579-13_s1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "S-1", "eventDate": "2025-11-21", "accession": "0001213900-25-113249", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025113249/0001213900-25-113249-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390025113249/ea0251239-04.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "DRS", "eventDate": "2025-11-21", "accession": "0001193125-25-290911", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312525290911/0001193125-25-290911-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312525290911/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-24", "accession": "0001193125-25-292397", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525292397/0001193125-25-292397-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525292397/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "UPLOAD", "eventDate": "2025-11-24", "accession": "0000000000-25-011001", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025011001/0000000000-25-011001-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000000000025011001/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-24", "accession": "0001104659-25-115350", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925115350/0001104659-25-115350-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925115350/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-24", "accession": "0001104659-25-115347", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925115347/0001104659-25-115347-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925115347/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-26", "accession": "0001104659-25-116380", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925116380/0001104659-25-116380-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925116380/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "CORRESP", "eventDate": "2025-11-26", "accession": "0001104659-25-116371", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925116371/0001104659-25-116371-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925116371/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1", "eventDate": "2025-11-28", "accession": "0001062993-25-017070", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299325017070/0001062993-25-017070-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299325017070/forms1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "UPLOAD", "eventDate": "2025-12-01", "accession": "0000000000-25-011150", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000025011150/0000000000-25-011150-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000025011150/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "CORRESP", "eventDate": "2025-12-02", "accession": "0001193125-25-304466", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525304466/0001193125-25-304466-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525304466/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "S-1/A", "eventDate": "2025-12-02", "accession": "0001193125-25-304460", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525304460/0001193125-25-304460-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525304460/d217676ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-69604", "company": "Park Dental Partners, Inc.", "cik": 2069604, "sector": "services", "form": "424B4", "eventDate": "2025-12-03", "accession": "0001104659-25-118023", "secUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925118023/0001104659-25-118023-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2069604/000110465925118023/tm2514579-16_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "CORRESP", "eventDate": "2025-12-08", "accession": "0001193125-25-311140", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525311140/0001193125-25-311140-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525311140/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "CORRESP", "eventDate": "2025-12-08", "accession": "0001193125-25-311137", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525311137/0001193125-25-311137-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525311137/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "S-1/A", "eventDate": "2025-12-08", "accession": "0001193125-25-311099", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525311099/0001193125-25-311099-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525311099/d55108ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-12-10", "accession": "0001628279-25-000828", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162827925000828/0001628279-25-000828-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162827925000828/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "DRS/A", "eventDate": "2025-12-12", "accession": "0001193125-25-317659", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312525317659/0001193125-25-317659-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312525317659/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-71288", "company": "Lumexa Imaging Holdings, Inc.", "cik": 2071288, "sector": "services", "form": "424B4", "eventDate": "2025-12-12", "accession": "0001193125-25-316455", "secUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525316455/0001193125-25-316455-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2071288/000119312525316455/d217676d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "S-1MEF", "eventDate": "2025-12-16", "accession": "0001193125-25-321162", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525321162/0001193125-25-321162-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525321162/d32065ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "424B4", "eventDate": "2025-12-18", "accession": "0001193125-25-323742", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525323742/0001193125-25-323742-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312525323742/d77351d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "S-1", "eventDate": "2025-12-19", "accession": "0001193125-25-326780", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312525326780/0001193125-25-326780-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312525326780/d875386ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "DRS", "eventDate": "2025-12-19", "accession": "0001193125-25-326945", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312525326945/0001193125-25-326945-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312525326945/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "DRS", "eventDate": "2025-12-19", "accession": "0001193125-25-326849", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312525326849/0001193125-25-326849-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312525326849/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "S-1", "eventDate": "2025-12-19", "accession": "0001628280-25-058231", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/0001628280-25-058231-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/minimedgroupincs-1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "form": "DRS", "eventDate": "2025-12-23", "accession": "0001193125-25-330964", "secUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312525330964/0001193125-25-330964-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312525330964/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-05", "accession": "0001193125-26-001466", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526001466/0001193125-26-001466-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526001466/d875386ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-07", "accession": "0001193125-26-005437", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526005437/0001193125-26-005437-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526005437/d827117ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-35832", "company": "Aktis Oncology, Inc.", "cik": 2035832, "sector": "biotech", "form": "424B4", "eventDate": "2026-01-09", "accession": "0001193125-26-009078", "secUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526009078/0001193125-26-009078-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526009078/d875386d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "DRS", "eventDate": "2026-01-09", "accession": "0001193125-26-009127", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526009127/0001193125-26-009127-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526009127/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "S-1", "eventDate": "2026-01-09", "accession": "0001193125-26-008888", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526008888/0001193125-26-008888-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526008888/d903262ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1", "eventDate": "2026-01-09", "accession": "0001213900-26-003037", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026003037/0001213900-26-003037-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026003037/ea0248668-05.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "DRS", "eventDate": "2026-01-09", "accession": "0001193125-26-009106", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526009106/0001193125-26-009106-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526009106/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "S-1", "eventDate": "2026-01-09", "accession": "0001628280-26-001651", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/0001628280-26-001651-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026001651/veradermicsincs-1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-01-13", "accession": "0000000000-26-000406", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000026000406/0000000000-26-000406-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000026000406/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-14", "accession": "0001213900-26-004079", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/0001213900-26-004079-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026004079/ea0251239-07.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-01-16", "accession": "0001628280-26-002359", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026002359/0001628280-26-002359-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026002359/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "S-1", "eventDate": "2026-01-16", "accession": "0001628280-26-002356", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026002356/0001628280-26-002356-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026002356/spyglass-sx1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "DRS", "eventDate": "2026-01-21", "accession": "0001489993-26-000003", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000148999326000003/0001489993-26-000003-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000148999326000003/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "S-1/A", "eventDate": "2026-01-23", "accession": "0001628280-26-003281", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026003281/0001628280-26-003281-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026003281/minimedgroupincs-1a1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2026-01-27", "accession": "0000000000-26-000836", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026000836/0000000000-26-000836-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026000836/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-27", "accession": "0001213900-26-007973", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026007973/0001213900-26-007973-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026007973/ea0251239-08.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-01-27", "accession": "0000000000-26-000806", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000026000806/0000000000-26-000806-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000000000026000806/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-28", "accession": "0001193125-26-025565", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526025565/0001193125-26-025565-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526025565/d903262ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-28", "accession": "0001628280-26-003764", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/0001628280-26-003764-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026003764/veradermicsincs-1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-01-29", "accession": "0001193125-26-027903", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526027903/0001193125-26-027903-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526027903/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-01-29", "accession": "0001628280-26-004094", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004094/0001628280-26-004094-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004094/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-01-29", "accession": "0001628280-26-004093", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004093/0001628280-26-004093-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004093/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-01-29", "accession": "0001628280-26-004092", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004092/0001628280-26-004092-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004092/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-01-29", "accession": "0001628280-26-004091", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004091/0001628280-26-004091-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026004091/spyglass-sx1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-75320", "company": "Polaryx Therapeutics, Inc.", "cik": 2075320, "sector": "biotech", "form": "424B4", "eventDate": "2026-02-02", "accession": "0001213900-26-010761", "secUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026010761/0001213900-26-010761-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026010761/ea0251239-09.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-02-03", "accession": "0001062993-26-000578", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326000578/0001062993-26-000578-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326000578/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-02-03", "accession": "0001628280-26-005218", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026005218/0001628280-26-005218-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026005218/veradermicsincs-1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-02-04", "accession": "0001193125-26-037993", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526037993/0001193125-26-037993-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526037993/d26375ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "form": "S-1", "eventDate": "2026-02-04", "accession": "0001193125-26-037799", "secUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526037799/0001193125-26-037799-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526037799/ck0002100782-20260204.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-02-04", "accession": "0001829126-26-000965", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626000965/0001829126-26-000965-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626000965/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "424B4", "eventDate": "2026-02-04", "accession": "0001628280-26-005505", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026005505/0001628280-26-005505-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026005505/veradermicsinc424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-61123", "company": "Eikon Therapeutics, Inc.", "cik": 1861123, "sector": "biotech", "form": "424B4", "eventDate": "2026-02-05", "accession": "0001193125-26-039375", "secUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526039375/0001193125-26-039375-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1861123/000119312526039375/d99350d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-02-05", "accession": "0001213900-26-012492", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026012492/0001213900-26-012492-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026012492/ea0248668-07.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "DRS", "eventDate": "2026-02-06", "accession": "0001193125-26-040979", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526040979/0001193125-26-040979-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526040979/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS", "eventDate": "2026-02-06", "accession": "0001193125-26-041396", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526041396/0001193125-26-041396-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526041396/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-78922", "company": "SpyGlass Pharma, Inc.", "cik": 1778922, "sector": "biotech", "form": "424B4", "eventDate": "2026-02-06", "accession": "0001628280-26-006068", "secUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026006068/0001628280-26-006068-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1778922/000162828026006068/spyglass-424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-02-11", "accession": "0001193125-26-046566", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526046566/0001193125-26-046566-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526046566/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-02-12", "accession": "0001193125-26-048782", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526048782/0001193125-26-048782-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526048782/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "UPLOAD", "eventDate": "2026-02-12", "accession": "0000000000-26-001524", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000000000026001524/0000000000-26-001524-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000000000026001524/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-02-13", "accession": "0001193125-26-051761", "secUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526051761/0001193125-26-051761-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526051761/generate_bio_s-1a_-_exh_.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-02-13", "accession": "0001213900-26-015814", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026015814/0001213900-26-015814-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026015814/ea0248668-09.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "DRS/A", "eventDate": "2026-02-17", "accession": "0001193125-26-054940", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526054940/0001193125-26-054940-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526054940/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-02-17", "accession": "0001193125-26-054701", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526054701/0001193125-26-054701-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526054701/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "DRS", "eventDate": "2026-02-20", "accession": "0001185185-26-000633", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526000633/0001185185-26-000633-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526000633/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-02-23", "accession": "0001193125-26-062362", "secUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526062362/0001193125-26-062362-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526062362/ck0002100782-20260223.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "S-1/A", "eventDate": "2026-02-24", "accession": "0001628280-26-010862", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026010862/0001628280-26-010862-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026010862/minimedgroupincs-1a2.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-00782", "company": "Generate Biomedicines, Inc.", "cik": 2100782, "sector": "biotech", "form": "424B4", "eventDate": "2026-02-27", "accession": "0001193125-26-083190", "secUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526083190/0001193125-26-083190-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2100782/000119312526083190/generate_bio_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "DRS", "eventDate": "2026-02-27", "accession": "0001193125-26-081986", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526081986/0001193125-26-081986-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526081986/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "S-1/A", "eventDate": "2026-02-27", "accession": "0001628280-26-012865", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026012865/0001628280-26-012865-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026012865/minimedgroupincs-1a3.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-02-27", "accession": "0001193125-26-083019", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526083019/0001193125-26-083019-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526083019/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "CORRESP", "eventDate": "2026-03-03", "accession": "0001193125-26-086630", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312526086630/0001193125-26-086630-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312526086630/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-03-05", "accession": "0001062993-26-001297", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001297/0001062993-26-001297-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001297/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-62583", "company": "MiniMed Group, Inc.", "cik": 2062583, "sector": "device", "form": "424B4", "eventDate": "2026-03-06", "accession": "0001628280-26-015648", "secUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026015648/0001628280-26-015648-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2062583/000162828026015648/minimedgroupinc424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-03-06", "accession": "0001193125-26-096844", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526096844/0001193125-26-096844-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526096844/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-03-11", "accession": "0001213900-26-026195", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026026195/0001213900-26-026195-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026026195/ea0248668-11.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "DRS/A", "eventDate": "2026-03-11", "accession": "0001628279-26-000298", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162827926000298/0001628279-26-000298-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162827926000298/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "DRS/A", "eventDate": "2026-03-12", "accession": "0001193125-26-104470", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526104470/0001193125-26-104470-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526104470/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-03-16", "accession": "0001193125-26-108608", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526108608/0001193125-26-108608-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526108608/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-03-18", "accession": "0001193125-26-113967", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526113967/0001193125-26-113967-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526113967/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "DRS/A", "eventDate": "2026-03-24", "accession": "0001628279-26-000342", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162827926000342/0001628279-26-000342-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162827926000342/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-03-26", "accession": "0001062993-26-001640", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001640/0001062993-26-001640-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001640/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "DRS", "eventDate": "2026-03-26", "accession": "0001193125-26-126541", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526126541/0001193125-26-126541-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526126541/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "S-1", "eventDate": "2026-03-27", "accession": "0001193125-26-129039", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526129039/0001193125-26-129039-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526129039/d39680ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "S-1", "eventDate": "2026-03-27", "accession": "0001193125-26-128952", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526128952/0001193125-26-128952-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526128952/d113532ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "DRS", "eventDate": "2026-03-27", "accession": "0001193125-26-129261", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526129261/0001193125-26-129261-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526129261/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-01", "accession": "0001213900-26-037938", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026037938/0001213900-26-037938-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026037938/ea0248668-12.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-04-02", "accession": "0001193125-26-140464", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526140464/0001193125-26-140464-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526140464/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "DRS", "eventDate": "2026-04-02", "accession": "0001193125-26-140488", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526140488/0001193125-26-140488-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526140488/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-04-02", "accession": "0001185185-26-001233", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526001233/0001185185-26-001233-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526001233/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-04-03", "accession": "0001193125-26-142305", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526142305/0001193125-26-142305-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526142305/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-06", "accession": "0001062993-26-001871", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001871/0001062993-26-001871-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001871/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-06", "accession": "0001213900-26-040254", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026040254/0001213900-26-040254-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026040254/ea0248668-13.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "UPLOAD", "eventDate": "2026-04-07", "accession": "0000000000-26-003476", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000026003476/0000000000-26-003476-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000000000026003476/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-04-07", "accession": "0000000000-26-003484", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000000000026003484/0000000000-26-003484-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000000000026003484/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "S-1", "eventDate": "2026-04-08", "accession": "0001193125-26-147573", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526147573/0001193125-26-147573-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526147573/ck0001540171-20260408.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-10", "accession": "0001062993-26-001914", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001914/0001062993-26-001914-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326001914/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "S-1", "eventDate": "2026-04-10", "accession": "0001193125-26-151378", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526151378/0001193125-26-151378-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526151378/d50309ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-04-10", "accession": "0001193125-26-151255", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312526151255/0001193125-26-151255-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000119312526151255/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-91082", "company": "LB PHARMACEUTICALS INC", "cik": 1691082, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-04-10", "accession": "0000000000-26-003643", "secUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000026003643/0000000000-26-003643-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1691082/000000000026003643/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "S-1", "eventDate": "2026-04-10", "accession": "0001193125-26-151211", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526151211/0001193125-26-151211-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526151211/d73463ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-13", "accession": "0001193125-26-151891", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526151891/0001193125-26-151891-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526151891/d39680ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-13", "accession": "0001193125-26-151904", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526151904/0001193125-26-151904-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526151904/d113532ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-16", "accession": "0001193125-26-158122", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526158122/0001193125-26-158122-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526158122/d39680ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "S-1MEF", "eventDate": "2026-04-16", "accession": "0001193125-26-159789", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526159789/0001193125-26-159789-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526159789/d620616ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-04-16", "accession": "0001193125-26-159585", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526159585/0001193125-26-159585-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526159585/d110326ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2026-04-16", "accession": "0000000000-26-003887", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026003887/0000000000-26-003887-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026003887/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-04204", "company": "Alamar Biosciences, Inc.", "cik": 2104204, "sector": "device", "form": "424B4", "eventDate": "2026-04-17", "accession": "0001193125-26-161647", "secUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526161647/0001193125-26-161647-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2104204/000119312526161647/d39680d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-78325", "company": "CapsoVision, Inc", "cik": 1378325, "sector": "device", "form": "CORRESP", "eventDate": "2026-04-17", "accession": "0001628280-26-025803", "secUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000162828026025803/0001628280-26-025803-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1378325/000162828026025803/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-17", "accession": "0001062993-26-002041", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326002041/0001062993-26-002041-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326002041/forms1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-96997", "company": "Kailera Therapeutics, Inc.", "cik": 2096997, "sector": "biotech", "form": "424B4", "eventDate": "2026-04-17", "accession": "0001193125-26-161521", "secUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526161521/0001193125-26-161521-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2096997/000119312526161521/d113532d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "S-1", "eventDate": "2026-04-17", "accession": "0001628280-26-025811", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026025811/0001628280-26-025811-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026025811/mobiamedical-sx1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "S-1", "eventDate": "2026-04-17", "accession": "0001193125-26-161514", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526161514/0001193125-26-161514-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526161514/odtx-20260417.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "UPLOAD", "eventDate": "2026-04-21", "accession": "0000000000-26-004039", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000000000026004039/0000000000-26-004039-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000000000026004039/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-04-22", "accession": "0001193125-26-167732", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526167732/0001193125-26-167732-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526167732/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-04-22", "accession": "0001193125-26-170867", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312526170867/0001193125-26-170867-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000119312526170867/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-44725", "company": "Evommune, Inc.", "cik": 2044725, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-04-22", "accession": "0000000000-26-004089", "secUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000026004089/0000000000-26-004089-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2044725/000000000026004089/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-23", "accession": "0001193125-26-173632", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526173632/0001193125-26-173632-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526173632/ck0001540171-20260423.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "424B4", "eventDate": "2026-04-23", "accession": "0001213900-26-047113", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026047113/0001213900-26-047113-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026047113/ea0248668-15.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "DRS", "eventDate": "2026-04-24", "accession": "0001193125-26-177693", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526177693/0001193125-26-177693-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526177693/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-27", "accession": "0001193125-26-178809", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/0001193125-26-178809-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/d50309ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "S-1/A", "eventDate": "2026-04-27", "accession": "0001628280-26-027560", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026027560/0001628280-26-027560-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026027560/mobiamedical-sx1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-04-27", "accession": "0001829126-26-003983", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626003983/0001829126-26-003983-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626003983/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-04-27", "accession": "0001829126-26-003982", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626003982/0001829126-26-003982-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626003982/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-27", "accession": "0001193125-26-178716", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526178716/0001193125-26-178716-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526178716/d73463ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-04-27", "accession": "0001628280-26-027635", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026027635/0001628280-26-027635-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026027635/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q1-27635", "company": "Veradermics, Inc", "cik": 1827635, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-04-27", "accession": "0001628280-26-027634", "secUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026027634/0001628280-26-027634-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1827635/000162828026027634/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-28", "accession": "0001193125-26-186964", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526186964/0001193125-26-186964-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526186964/d50309ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-29", "accession": "0001193125-26-189477", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526189477/0001193125-26-189477-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526189477/ck0001540171-20260429.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "DRS", "eventDate": "2026-04-29", "accession": "0001628279-26-000549", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162827926000549/0001628279-26-000549-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162827926000549/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-40171", "company": "Avalyn Pharma Inc.", "cik": 1540171, "sector": "biotech", "form": "424B4", "eventDate": "2026-04-30", "accession": "0001193125-26-197686", "secUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/0001193125-26-197686-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1540171/000119312526197686/424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-04-30", "accession": "0001193125-26-193885", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526193885/0001193125-26-193885-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526193885/d50309ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-04-30", "accession": "0001193125-26-197828", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526197828/0001193125-26-197828-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526197828/d133636ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-04-30", "accession": "0001829126-26-004278", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004278/0001829126-26-004278-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004278/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-04-30", "accession": "0001829126-26-004277", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004277/0001829126-26-004277-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004277/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-04-30", "accession": "0001193125-26-198107", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526198107/0001193125-26-198107-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526198107/d113209ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-14044", "company": "Hemab Therapeutics Holdings, Inc.", "cik": 2114044, "sector": "biotech", "form": "424B4", "eventDate": "2026-05-01", "accession": "0001193125-26-201458", "secUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526201458/0001193125-26-201458-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2114044/000119312526201458/d50309d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-42347", "company": "Seaport Therapeutics, Inc.", "cik": 2042347, "sector": "biotech", "form": "424B4", "eventDate": "2026-05-01", "accession": "0001193125-26-201758", "secUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526201758/0001193125-26-201758-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2042347/000119312526201758/d73463d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-05-04", "accession": "0001193125-26-202951", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526202951/0001193125-26-202951-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526202951/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "S-1/A", "eventDate": "2026-05-04", "accession": "0001628280-26-029505", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026029505/0001628280-26-029505-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026029505/mobiamedical-sx1a2.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-05-04", "accession": "0001193125-26-202398", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526202398/0001193125-26-202398-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526202398/odtx-20260504.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-05-04", "accession": "0001829126-26-004417", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004417/0001829126-26-004417-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004417/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-05-04", "accession": "0001829126-26-004415", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004415/0001829126-26-004415-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000182912626004415/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-05-07", "accession": "0001193125-26-212775", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526212775/0001193125-26-212775-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526212775/odtx-20260507.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "UPLOAD", "eventDate": "2026-05-08", "accession": "0000000000-26-004726", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000000000026004726/0000000000-26-004726-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000000000026004726/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-89993", "company": "Mobia Medical, Inc.", "cik": 1489993, "sector": "device", "form": "424B4", "eventDate": "2026-05-08", "accession": "0001628280-26-032843", "secUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026032843/0001628280-26-032843-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1489993/000162828026032843/mobiamedical-424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-82782", "company": "Odyssey Therapeutics, Inc.", "cik": 1882782, "sector": "biotech", "form": "424B4", "eventDate": "2026-05-08", "accession": "0001193125-26-214819", "secUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526214819/0001193125-26-214819-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1882782/000119312526214819/odyssey__form_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-66836", "company": "Conexeu Sciences Inc.", "cik": 2066836, "sector": "device", "form": "424B4", "eventDate": "2026-05-11", "accession": "0001062993-26-002473", "secUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326002473/0001062993-26-002473-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2066836/000106299326002473/form424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-79272", "company": "Lakewood-Amedex Biotherapeutics Inc.", "cik": 2079272, "sector": "biotech", "form": "CORRESP", "eventDate": "2026-05-12", "accession": "0001213900-26-054931", "secUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026054931/0001213900-26-054931-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2079272/000121390026054931/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-05-18", "accession": "0001193125-26-227442", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526227442/0001193125-26-227442-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526227442/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "S-1", "eventDate": "2026-05-19", "accession": "0001193125-26-230994", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526230994/0001193125-26-230994-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526230994/ck0001657677-20260519.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q4-46386", "company": "Medline Inc.", "cik": 2046386, "sector": "device", "form": "CORRESP", "eventDate": "2026-05-20", "accession": "0001193125-26-231698", "secUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312526231698/0001193125-26-231698-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2046386/000119312526231698/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "S-1", "eventDate": "2026-05-26", "accession": "0001193125-26-239298", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526239298/0001193125-26-239298-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526239298/d107928ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "UPLOAD", "eventDate": "2026-05-26", "accession": "0000000000-26-005353", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026005353/0000000000-26-005353-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000000000026005353/filename1.pdf", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-05-27", "accession": "0001193125-26-242067", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526242067/0001193125-26-242067-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526242067/pbls_s-1a_1_exhibit_only.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2025Q3-30617", "company": "Picard Medical, Inc.", "cik": 2030617, "sector": "device", "form": "CORRESP", "eventDate": "2026-05-27", "accession": "0001437749-26-018559", "secUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000143774926018559/0001437749-26-018559-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2030617/000143774926018559/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-01", "accession": "0001193125-26-249229", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526249229/0001193125-26-249229-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526249229/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-06-04", "accession": "0001193125-26-256398", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526256398/0001193125-26-256398-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526256398/ck0001657677-20260604.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-05", "accession": "0001193125-26-259800", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526259800/0001193125-26-259800-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526259800/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-05", "accession": "0001193125-26-259845", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526259845/0001193125-26-259845-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526259845/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-08", "accession": "0001628279-26-000717", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162827926000717/0001628279-26-000717-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162827926000717/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-06-09", "accession": "0001193125-26-262880", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526262880/0001193125-26-262880-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526262880/ck0001657677-20260609.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-06-09", "accession": "0001193125-26-264426", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526264426/0001193125-26-264426-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526264426/ck0001657677-20260609.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-57677", "company": "Parabilis Medicines, Inc.", "cik": 1657677, "sector": "biotech", "form": "424B4", "eventDate": "2026-06-10", "accession": "0001193125-26-265983", "secUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526265983/0001193125-26-265983-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1657677/000119312526265983/pbls_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-11", "accession": "0001193125-26-267857", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526267857/0001193125-26-267857-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526267857/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-06-11", "accession": "0001193125-26-266629", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526266629/0001193125-26-266629-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526266629/d107928ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-12", "accession": "0001193125-26-269670", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526269670/0001193125-26-269670-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526269670/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-06-17", "accession": "0001193125-26-274688", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526274688/0001193125-26-274688-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526274688/d132513ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q2-23613", "company": "Kardigan, Inc.", "cik": 2123613, "sector": "biotech", "form": "424B4", "eventDate": "2026-06-18", "accession": "0001193125-26-276096", "secUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526276096/0001193125-26-276096-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2123613/000119312526276096/d107928d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "DRS", "eventDate": "2026-06-26", "accession": "0001193125-26-285726", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526285726/0001193125-26-285726-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526285726/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-06-30", "accession": "0001185185-26-002747", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526002747/0001185185-26-002747-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526002747/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-02", "accession": "0001193125-26-294804", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/0001193125-26-294804-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526294804/d21355ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-10", "accession": "0001193125-26-300909", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526300909/0001193125-26-300909-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526300909/apni-20260710.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-10", "accession": "0001193125-26-300994", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526300994/0001193125-26-300994-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526300994/d21355ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-14", "accession": "0001193125-26-303256", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526303256/0001193125-26-303256-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526303256/d40469ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-15", "accession": "0001628280-26-048213", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026048213/0001628280-26-048213-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026048213/braveheartbioinc-sx1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-15", "accession": "0001185185-26-002985", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526002985/0001185185-26-002985-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526002985/vogenxs1071026.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-17", "accession": "0001193125-26-306506", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526306506/0001193125-26-306506-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526306506/d98958ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "S-1", "eventDate": "2026-07-17", "accession": "0001193125-26-307306", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526307306/0001193125-26-307306-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526307306/d38775ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-20", "accession": "0001193125-26-308330", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/0001193125-26-308330-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526308330/d21355ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-07-23", "accession": "0001193125-26-314695", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526314695/0001193125-26-314695-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526314695/d113461ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-27", "accession": "0001193125-26-316811", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526316811/0001193125-26-316811-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526316811/apni-20260727.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-53921", "company": "Scribe Therapeutics, Inc.", "cik": 1853921, "sector": "biotech", "form": "424B4", "eventDate": "2026-07-27", "accession": "0001193125-26-316503", "secUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526316503/0001193125-26-316503-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1853921/000119312526316503/d21355d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-29", "accession": "0001193125-26-323618", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526323618/0001193125-26-323618-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526323618/d40469ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-29", "accession": "0001185185-26-003162", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003162/0001185185-26-003162-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003162/vogenxs1a1072526.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-07-30", "accession": "0001193125-26-326515", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526326515/0001193125-26-326515-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526326515/apni-20260730.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-07-30", "accession": "0001628280-26-050756", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026050756/0001628280-26-050756-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026050756/braveheartbioinc-sx1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-45648", "company": "Apnimed, Inc.", "cik": 1745648, "sector": "biotech", "form": "424B4", "eventDate": "2026-07-31", "accession": "0001193125-26-328422", "secUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526328422/0001193125-26-328422-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1745648/000119312526328422/apmd_424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-08-03", "accession": "0001193125-26-329416", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526329416/0001193125-26-329416-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526329416/d98958ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-08-03", "accession": "0001193125-26-329431", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526329431/0001193125-26-329431-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526329431/d38775ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-08-04", "accession": "0001193125-26-331510", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526331510/0001193125-26-331510-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526331510/d40469ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-08-04", "accession": "0001193125-26-331205", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526331205/0001193125-26-331205-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526331205/d38775ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-58707", "company": "Attovia Therapeutics, Inc.", "cik": 2058707, "sector": "biotech", "form": "424B4", "eventDate": "2026-08-05", "accession": "0001193125-26-334997", "secUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526334997/0001193125-26-334997-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2058707/000119312526334997/d40469d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-08-05", "accession": "0001628280-26-053690", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026053690/0001628280-26-053690-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026053690/braveheart-sx1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-08-06", "accession": "0001193125-26-338734", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526338734/0001193125-26-338734-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526338734/d144811ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-31524", "company": "Braveheart Bio, Inc.", "cik": 2131524, "sector": "biotech", "form": "424B4", "eventDate": "2026-08-06", "accession": "0001628280-26-054354", "secUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026054354/0001628280-26-054354-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2131524/000162828026054354/braveheartbioinc-sx1a2.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-08-06", "accession": "0001193125-26-338412", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526338412/0001193125-26-338412-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526338412/d23001ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-39970", "company": "BlossomHill Therapeutics, Inc.", "cik": 1839970, "sector": "biotech", "form": "424B4", "eventDate": "2026-08-07", "accession": "0001193125-26-340215", "secUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526340215/0001193125-26-340215-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1839970/000119312526340215/d98958d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-56611", "company": "Latigo Biotherapeutics, Inc.", "cik": 2056611, "sector": "biotech", "form": "424B4", "eventDate": "2026-08-07", "accession": "0001193125-26-340329", "secUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526340329/0001193125-26-340329-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2056611/000119312526340329/d38775d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "DRS/A", "eventDate": "2026-08-10", "accession": "0001193125-26-342694", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526342694/0001193125-26-342694-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526342694/filename1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-08-10", "accession": "0001185185-26-003353", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003353/0001185185-26-003353-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003353/vogenxs1a2080126.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-03784", "company": "Vogenx, Inc.", "cik": 1903784, "sector": "biotech", "form": "424B4", "eventDate": "2026-08-12", "accession": "0001185185-26-003448", "secUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003448/0001185185-26-003448-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/1903784/000118518526003448/vogenx424b4081126.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "S-1", "eventDate": "2026-08-28", "accession": "0001193125-26-374259", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526374259/0001193125-26-374259-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526374259/d61940ds1.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "S-1/A", "eventDate": "2026-09-14", "accession": "0001193125-26-389755", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526389755/0001193125-26-389755-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526389755/d61940ds1a.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "S-1MEF", "eventDate": "2026-09-17", "accession": "0001193125-26-394715", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526394715/0001193125-26-394715-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526394715/d381165ds1mef.htm", "evidenceExtracted": "filing date and link only", "verified": "2026-09", "status": "verified against EDGAR submissions record" }, { "issuerId": "LSH-2026Q3-88082", "company": "Electra Therapeutics, Inc.", "cik": 2088082, "sector": "biotech", "form": "424B4", "eventDate": "2026-09-18", "accession": "0001193125-26-395670", "secUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/0001193125-26-395670-index.htm", "documentUrl": "https://www.sec.gov/Archives/edgar/data/2088082/000119312526395670/d61940d424b4.htm", "evidenceExtracted": "themes from final prospectus text", "verified": "2026-09", "status": "verified against EDGAR submissions record" } ] }